Search Prime Grants

R01NS124222

Project Grant

Overview

Grant Description
Regenerative Ultramicroelectrode Arrays for Sensory-Motor Specific Interfacing - Project Summary

Approximately 4 million amputees globally, a number estimated to grow 200,000 annually. Upper limb amputees traditionally use passive, body powered, or electrically powered prostheses that use surface electromyographic (EMG) signals from intact muscles in the residual limb for movement, despite the motion artifacts, variability, and need of visual and/or surrogate sensory control by the user.

Advanced peripheral nervous system (PNS) interfaces have been proposed as a viable mechanism to improve the control by amputees, by reading naturalistic sensory feedback from the robotic prosthetics. Unfortunately, current neural interfaces suffer from common challenges, and electrode failure, signal deterioration over time, EMG contamination and electrical and unstable sensory percepts, including "stings or tingles" remain a challenge.

This study is uses two novel strategies designed to increase the selectivity of recording/stimulation at the PNS interface: 1) the use of an innovative regenerative multi-electrode interface with ultra-small recording sites using our recently developed ultra-thin multielectrode array, and 2) incorporation of molecular guidance cues to influence the type of sensory neurons at the neural interface.

This selectivity regenerative ultramicro multielectrode array (RUMEA) is designed to discriminate between motor and cutaneous neural interfacing by combining it with molecular guidance to biologically engineer the content of sensory-motor axons at the electrode interface. Three specific aims are included:

In SA1, 36-electrode RUMAs, straight and Y-shape devices, will be fabricated and electrochemical and mechanical tested.

In SA2, we seek to demonstrate selective recording from motor axons and evoke touch percepts using the RUMA.

In SA3, we will demonstrate selective interfacing of motor and tactile axons in an upper limb amputee rat model of bidirectional nerve machine interface using molecularly guided RUMAs.

If successful, this strategy will demonstrate the benefit for using RUMA for selective recording from motor axons, and stimulation of sensory modality axons that evoke naturalistic sensory percepts. This advancement in peripheral neural interfaces for amputees will reduce the cognitive burden for users of robotic prosthetics and decrease the abnormal sensations associated with electrical stimulation in the PNS.
Funding Goals
(1) TO SUPPORT EXTRAMURAL RESEARCH FUNDED BY THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (NINDS) INCLUDING: BASIC RESEARCH THAT EXPLORES THE FUNDAMENTAL STRUCTURE AND FUNCTION OF THE BRAIN AND THE NERVOUS SYSTEM, RESEARCH TO UNDERSTAND THE CAUSES AND ORIGINS OF PATHOLOGICAL CONDITIONS OF THE NERVOUS SYSTEM WITH THE GOAL OF PREVENTING THESE DISORDERS, RESEARCH ON THE NATURAL COURSE OF NEUROLOGICAL DISORDERS, IMPROVED METHODS OF DISEASE PREVENTION, NEW METHODS OF DIAGNOSIS AND TREATMENT, DRUG DEVELOPMENT, DEVELOPMENT OF NEURAL DEVICES, CLINICAL TRIALS, AND RESEARCH TRAINING IN BASIC, TRANSLATIONAL AND CLINICAL NEUROSCIENCE. THE INSTITUTE IS THE LARGEST FUNDER OF BASIC NEUROSCIENCE IN THE US AND SUPPORTS RESEARCH ON TOPICS INCLUDING BUT NOT LIMITED TO: DEVELOPMENT OF THE NERVOUS SYSTEM, INCLUDING NEUROGENESIS AND PROGENITOR CELL BIOLOGY, SIGNAL TRANSDUCTION IN DEVELOPMENT AND PLASTICITY, AND PROGRAMMED CELL DEATH, SYNAPSE FORMATION, FUNCTION, AND PLASTICITY, LEARNING AND MEMORY, CHANNELS, TRANSPORTERS, AND PUMPS, CIRCUIT FORMATION AND MODULATION, BEHAVIORAL AND COGNITIVE NEUROSCIENCE, SENSORIMOTOR LEARNING, INTEGRATION AND EXECUTIVE FUNCTION, NEUROENDOCRINE SYSTEMS, SLEEP AND CIRCADIAN RHYTHMS, AND SENSORY AND MOTOR SYSTEMS. IN ADDITION, THE INSTITUTE SUPPORTS BASIC, TRANSLATIONAL AND CLINICAL STUDIES ON A NUMBER OF DISORDERS OF THE NERVOUS SYSTEM INCLUDING (BUT NOT LIMITED TO): STROKE, TRAUMATIC INJURY TO THE BRAIN, SPINAL CORD AND PERIPHERAL NERVOUS SYSTEM, NEURODEGENERATIVE DISORDERS, MOVEMENT DISORDERS, BRAIN TUMORS, CONVULSIVE DISORDERS, INFECTIOUS DISORDERS OF THE BRAIN AND NERVOUS SYSTEM, IMMUNE DISORDERS OF THE BRAIN AND NERVOUS SYSTEM, INCLUDING MULTIPLE SCLEROSIS, DISORDERS RELATED TO SLEEP, AND PAIN. PROGRAMMATIC AREAS, WHICH ARE PRIMARILY SUPPORTED BY THE DIVISION OF NEUROSCIENCE, ARE ALSO SUPPORTED BY THE DIVISION OF EXTRAMURAL ACTIVITIES, THE DIVISION OF TRANSLATIONAL RESEARCH, THE DIVISION OF CLINICAL RESEARCH, THE OFFICE OF TRAINING AND WORKFORCE DEVELOPMENT, THE OFFICE OF PROGRAMS TO ENHANCE NEUROSCIENCE WORKFORCE DEVELOPMENT, AND THE OFFICE OF INTERNATIONAL ACTIVITIES. (2) TO EXPAND AND IMPROVE THE SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. TO UTILIZE THE SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM, TO STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Place of Performance
Arizona United States
Geographic Scope
State-Wide
Analysis Notes
Amendment Since initial award the total obligations have increased 553% from $585,250 to $3,819,228.
University Of Arizona was awarded Regenerative Ultramicroelectrode Arrays Enhanced Sensory-Motor Interfacing Project Grant R01NS124222 worth $3,819,228 from the National Institute of Neurological Disorders and Stroke in September 2021 with work to be completed primarily in Arizona United States. The grant has a duration of 4 years 9 months and was awarded through assistance program 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders. The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).

Status
(Ongoing)

Last Modified 7/3/25

Period of Performance
9/1/21
Start Date
6/30/26
End Date
87.0% Complete

Funding Split
$3.8M
Federal Obligation
$0.0
Non-Federal Obligation
$3.8M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to R01NS124222

Subgrant Awards

Disclosed subgrants for R01NS124222

Transaction History

Modifications to R01NS124222

Additional Detail

Award ID FAIN
R01NS124222
SAI Number
R01NS124222-3390803423
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NQ00 NIH National Institute of Neurological Disorders and Stroke
Funding Office
75NQ00 NIH National Institute of Neurological Disorders and Stroke
Awardee UEI
ED44Y3W6P7B9
Awardee CAGE
0LJH3
Performance District
AZ-90
Senators
Kyrsten Sinema
Mark Kelly

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Health and Human Services (075-0886) Health research and training Grants, subsidies, and contributions (41.0) $1,118,187 100%
Modified: 7/3/25